Related Experiment Video
Updated: Apr 9, 2026
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis
Natalya Benderska1, Anna-Lena Dittrich, Sabine Knaup
1*Department of Experimental Tumor Pathology, Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; †Institute of Pathology, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; ‡First Department of Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; Departments of §Urology and ‖Pediatrics and Adolescent Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany; ¶Stratifyer Molecular Pathology GmbH, Cologne, Germany; **Faculty of School of Chemical and Biotechnology, SASTRA University, Thanjavur, India; ††Institute of Pathology, University Regensburg, Regensburg, Germany; and ‡‡Department of Basic Biomedical Sciences, Laboratory of Biology, School of Medicine, University of Athens, Athens, Greece.
MicroRNA-26b (miR-26b) is upregulated in ulcerative colitis-associated colorectal carcinoma (UCC) and can help predict cancer development. This microRNA may also distinguish UCC from sporadic colon cancer.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Ulcerative colitis (UC) significantly increases colorectal cancer risk.
- Inflammation alters microRNA expression, impacting gene regulation in UC-associated colorectal carcinoma (UCC).
- MicroRNA-26b (miR-26b) plays a role in normal tissue growth and differentiation.
Purpose of the Study:
- To investigate the role of miR-26b in inflammation-associated colorectal carcinogenesis.
- To determine if miR-26b can serve as a biomarker for UCC.
Main Methods:
- Analysis of miR-26b expression in patient tissues and serum using in situ hybridization and qPCR.
- In silico analysis, RNA immunoprecipitation, and luciferase assays for target validation.
- Overexpression of miR-26b mimic to study its functional impact.
Main Results:
- miR-26b expression was elevated in UC and UCC tissues and serum, correlating with disease progression.
- High accuracy in predicting UCC using miR-26b and Ki-67 expression levels.
- Identified DIP1, MDM2, CREBBP, and BRCA1 as novel miR-26b targets; DIP1 downregulation linked to kinase stabilization.
Conclusions:
- miR-26b shows potential as a biomarker for gastrointestinal inflammation.
- miR-26b can differentiate UCC from sporadic colon cancer due to differing expression patterns.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...